Global stock markets surge after Pfizer Covid vaccine news

Global stocks have surged after drug companies Pfizer and BioNTech announced that their coronavirus vaccine was 90% effective in tests, giving hope that economies around the world can soon return to normal.



a child looking at the camera: Photograph: AP


© Provided by The Guardian
Photograph: AP

The FTSE 100 soared on Monday by 5.5% to 6,242 points, up 332 points, its highest since mid-August. Most of the increase happened immediately after the vaccine announcement was first reported just before midday in London.

On Wall Street, the benchmark S&P 500 index was on track to surge 3.9% when trading begins, according to stock market futures.

Related: Global stocks hit record high on Biden victory and Covid-19 vaccine news – business live

Video: U.S. job growth slows; millions experiencing long bouts of unemployment (Reuters)

U.S. job growth slows; millions experiencing long bouts of unemployment

What to watch next

  • BP swings back to profit, epidemic uncertainty weighs

    BP swings back to profit, epidemic uncertainty weighs

    Reuters Logo

    Reuters

  • Investors line up for Ant Group's record $34.4 billion IPO

    Investors line up for Ant Group’s record $34.4 billion IPO

    Reuters Logo

    Reuters

  • Holiday shoppers are coming to town with health checklist, survey shows

    Holiday shoppers are coming to town with health checklist, survey shows

    Reuters Logo

    Reuters

  • Fiat, PSA to win EU approval for $38 billion merger - sources

    Fiat, PSA to win EU approval for $38 billion merger – sources

    Reuters Logo

    Reuters

  • Lee Kun-hee, who made South Korea's Samsung a global powerhouse, dies at 78

    Lee Kun-hee, who made South Korea’s Samsung a global powerhouse, dies at 78

    Reuters Logo

    Reuters

  • AstraZeneca resumes U.S. COVID-19 vaccine trial and next week J&J prepares to do same

    AstraZeneca resumes U.S. COVID-19 vaccine trial and next week J&J prepares to do same

    Reuters Logo

    Reuters

  • AstraZeneca resumes U.S. COVID-19 vaccine trial and next week J&J prepares to do same

    AstraZeneca resumes U.S. COVID-19 vaccine trial and next week J&J prepares to do same

    Reuters Logo

    Reuters

  • Back at the Brexit table, UK and EU try to land deal on fish

    Back at the Brexit table, UK and EU try to land deal on fish

    Reuters Logo

    Reuters

  • Britain signs first major post-Brexit trade deal with Japan

    Britain signs first major post-Brexit trade deal with Japan

    Reuters Logo

    Reuters

  • Goldman to pay $3 billion, claw back executive pay over role in 1MDB corruption scandal

    Goldman to pay $3 billion, claw back executive pay over role in 1MDB corruption scandal

    Reuters Logo

    Reuters

  • Time running short, UK and EU get back down to business

    Time running short, UK and EU get back down to business

    Reuters Logo

    Reuters

  • Britain steps up haulage preparations for busiest trade route post-Brexit

    Britain steps up haulage preparations for busiest trade route post-Brexit

    Reuters Logo

    Reuters

  • British Airways warns of deepening travel slump as losses mount

    British Airways warns of deepening travel slump as losses mount

    Reuters Logo

    Reuters

  • Unilever's sales rebound masks murky outlook

    Unilever’s sales rebound masks murky outlook

    Reuters Logo

    Reuters

  • Tesla sets revenue record, makes profit thanks to pollution credit sales to rivals

    Tesla sets revenue record, makes profit thanks to pollution credit sales to rivals

    Reuters Logo

    Reuters

  • PayPal to allow cryptocurrency buying, selling and shopping on its network

    PayPal to allow cryptocurrency buying, selling and shopping on its network

    Reuters Logo

    Reuters

UP NEXT

UP NEXT

Many of the biggest stock market gainers on Monday were the companies most affected by restrictions on movement brought in to fight the pandemic.

On the FTSE 100 they included shares in events company Informa, which soared by 44%, British Airways owner International Airlines Group, which gained 39%, and jet engine manufacturer and maintenance company Rolls-Royce, which gained 33%.

Pfizer and BioNTech said the vaccine was “found to be more than 90% effective in preventing Covid-19 in participants without evidence of prior Sars-CoV-2 infection in the first interim efficacy analysis”.

Stock markets had already gained ground as investors digested the US election result. President-elect Joe Biden was projected to have a firm lead in the electoral college, despite the Democratic party’s apparent failure to win back control of the Senate.

Neil Wilson, the chief market analyst for Markets.com, said: “While we are not there yet, news that this vaccine could be highly effective is the best thing markets could hope for.

“Public health officials will remind us there is a long road ahead, and many challenges will be faced along the way, but there is an enormous sense of optimism today – light at the end of the tunnel. Let’s just hope the vaccine deniers won’t get in the way, but 2021 just got a lot brighter.”



A patient in Pfizer’s Covid-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore.


© Photograph: AP
A patient in Pfizer’s Covid-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore.